Patents by Inventor David Michod

David Michod has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RasGAP derived peptide for selectively killing cancer cells
    Patent number: 8110544
    Abstract: The present invention relates to a peptide consisting in the N2 sequence of the RasGAP protein, a fragment thereof, or a variant thereof which enhances the ability of a drug to selectively kill cells. Furthermore, it relates to a pharmaceutical composition comprising as an active substance a pharmaceutically effective amount of the peptide.
    Type: Grant
    Filed: June 30, 2004
    Date of Patent: February 7, 2012
    Assignee: Universite de Lausanne
    Inventors: Christian Widmann, Jiang-Yang Yang, David Michod
  • Rasgap derived peptide for selectively killing cancer cells
    Publication number: 20060234929
    Abstract: The present invention relates to a peptide consisting in the N2 sequence of the RasGAP protein, a fragment thereof, or a variant thereof which enhances the ability of a drug to selectively kill cells. Furthermore, it relates to a pharmaceutical composition comprising as an active substance a pharmaceutically effective amount of said peptide.
    Type: Application
    Filed: June 30, 2004
    Publication date: October 19, 2006
    Inventors: Christian Widmann, Jiang-Yang Yang, David Michod